Company Filing History:
3 out of 26 
2 out of 35 Years Active: 2016-2017
Title: The Innovative Contributions of Yukio Sudo in Antibody Development
Introduction
Yukio Sudo, a prominent inventor based in Tokyo, Japan, has made significant contributions to the field of biotechnology with his groundbreaking inventions. With a total of three patents to his name, Sudo has focused his efforts on developing specific antibodies that target the transferrin receptor, which plays a crucial role in cancer cell growth and survival.
Latest Patents
One of Sudo's latest patents involves an antibody capable of specifically recognizing the transferrin receptor (TfR). The objective of this invention is to provide a complete human anti-human TfR antibody that can inhibit the survival or growth of cancer cells highly expressing TfR while exhibiting no immunogenicity to humans. His patent details an antibody that comprises various amino acid sequences, each corresponding to the heavy chain and light chain complementarity determining regions. This innovation is vital in advancing targeted therapies for cancer treatment.
Career Highlights
Throughout his career, Yukio Sudo has been affiliated with notable organizations, including Perseus Proteomics Inc. and the University of Miyazaki. His work has contributed to advancing the understanding of antibody development and its applications in medicine, particularly in the field of oncology.
Collaborations
Sudo has collaborated with distinguished colleagues, including Katsuyuki Mitomo and Yoshikazu Kurosawa. Their combined expertise and efforts have fostered innovation in the field, resulting in significant advancements in therapeutic antibody technologies.
Conclusion
Yukio Sudo's innovative work on specific antibodies targeting the transferrin receptor positions him as an influential figure in biotechnology. His inventions hold promise for improving cancer treatments, showcasing his dedication to enhancing human health through scientific discovery. As he continues to forge new paths in research, the impact of his contributions will likely resonate throughout the medical community and beyond.